{"name":"Allarity Therapeutics","slug":"allarity-therapeutics","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":6601000,"netIncome":-11231000,"cash":14687000,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"date":"2026-04-01","type":"regulatory","source":"SEC EDGAR","summary":"8-K filed with SEC: CURRENT REPORT","headline":"SEC 8-K: CURRENT REPORT","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi7gFBVV95cUxOS1I1R2dtcUd1ODZ3TE9kUDRoQ0NfNUhyWnk1QTRQcWdmeGNPSXJ4WTJzVkh3UVBBRklKaDItbzhzdWVRdFU5VTBCT0dFZmM3MmhybUYyYllkNzNieWNfM091dk56bkFWNGFBVm5tVkFWVmV4TnZxTkVvS1pFNmRXMEdObE1yZDBNZTNPdDhCRm9FZ1NCSUhHX3NLS00tNnpZTFdmbFVySDlfcGNUMzc1SmdvZGVpQmR3SmhoclJFZVptc3lFV1QtaXZDMUdSQTFRcm5udGtwYmJKNDVmRHgtYmFwSlUtaTlDOEU5Nm53?oc=5","date":"2026-03-31","type":"pipeline","source":"GlobeNewswire","summary":"Allarity Therapeutics Reports Full Year 2025 Financial Results and Corporate Progress - GlobeNewswire","headline":"Allarity Therapeutics Reports Full Year 2025 Financial Results and Corporate Progress","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMisgFBVV95cUxQSTcyTVV2dGV1eVdKZnVWY2FzaURyRTZNYTA0UDZrUzJGMDc1UlhQajVMUGtKaTMta3V1MmJQMnlXSjdiLWJhN21ESVV4bUdySmVCakVwR0JYaEFlNEJTT01OREtIblhSbXZtRG5VSnhTa3lTeTluT0NnSlR2WGx1eDY1OEdjLWNjNkEyNEt5VHZLb2h1WkZXb2FoT2RCTTc0TmM1UF9xTkdGY3ptQm5FYWFB?oc=5","date":"2026-03-30","type":"pipeline","source":"Stock Titan","summary":"Stenoparib push: Allarity Therapeutics (NASDAQ: ALLR) reshapes cancer pipeline - Stock Titan","headline":"Stenoparib push: Allarity Therapeutics (NASDAQ: ALLR) reshapes cancer pipeline","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMihgJBVV95cUxNYmVyVlB4UG1ZUXhpb2dDRVdwQnp4UjZ4WEc1RVBnTzQ1WktIZmVFYU5xcE1oR1NHQi1DbXU0dE50dnUxY3hSbTVzVEdDRHljdFZMdVJlLXNDY3VhWXgzVjczNUx0VFM1ZHJCSnM0Vm5wYVZaRG5zRExIQm9EZjBGSHhnd2NkV0d3OEF5UzlEZFRpZzNGQlVzWjctVzYtZWhGa0dsNVVTcUFJUUZTdTY5aUNTUlhDSXZPYTV2WDUyM2xtOHlCbF9VeWdvRmgzSGtxbkdZamZzaFkxYU1nekFhd1BpX2ZHRkctOWpjTFhHWkd2TVRzSkR1cWRvU2ZEYnVuMmtxNXV3?oc=5","date":"2026-03-30","type":"trial","source":"Barchart.com","summary":"Gastrointestinal Stromal Tumors Clinical Trial Pipeline Expands as 25+ Companies Driving Innovation in the Therapeutics | DelveInsight - Barchart.com","headline":"Gastrointestinal Stromal Tumors Clinical Trial Pipeline Expands as 25+ Companies Driving Innovation in the Therapeutics ","sentiment":"neutral"},{"date":"2026-03-30","type":"earnings","source":"SEC EDGAR","summary":"10-K filed with SEC: FORM 10-K","headline":"Annual Report (10-K) Filed","sentiment":"neutral"},{"date":"2026-03-09","type":"regulatory","source":"SEC EDGAR","summary":"8-K filed with SEC: CURRENT REPORT","headline":"SEC 8-K: CURRENT REPORT","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi7wFBVV95cUxNYVNTXzVxdVdwUFZkTW5vQ0YyQWtJazZ6WERkeFo1Z3lETHAwNUFOMXljZFBTbEUzMGpwWHZFOGRsUnVGRTBocUMzQW14cnNsZ00xUHJjTHJwZlpOZ3pMb0dVMzBMNUI3bmVqbEZhaDdLZ0xiZHZFVUNZamFKcEVQYnpESmo1WnlqUDFIMW1GRTZIWk9sRGFyVkhualZaTk5LSHhrcS13X1ZEUlpQbXJVYWhic3VxQ0ZKQXA3ajhuQkJmOVh5cWRVOTBVX2pLWFlGYjh4RTB1bkF2RUtDNk1WQnNhWVl3NXkwVTMxVFY1dw?oc=5","date":"2026-03-06","type":"regulatory","source":"Investing News Network","summary":"Allarity Therapeutics Closes $20 Million Financing to Accelerate the Advance of Stenoparib Toward FDA Approval and Commercialization - Investing News Network","headline":"Allarity Therapeutics Closes $20 Million Financing to Accelerate the Advance of Stenoparib Toward FDA Approval and Comme","sentiment":"positive"},{"date":"2026-03-06","type":"regulatory","source":"SEC EDGAR","summary":"8-K filed with SEC: CURRENT REPORT","headline":"SEC 8-K: CURRENT REPORT","sentiment":"neutral"},{"date":"2026-02-19","type":"regulatory","source":"SEC EDGAR","summary":"8-K filed with SEC: CURRENT REPORT","headline":"SEC 8-K: CURRENT REPORT","sentiment":"neutral"},{"date":"2026-02-04","type":"regulatory","source":"SEC EDGAR","summary":"8-K filed with SEC: CURRENT REPORT","headline":"SEC 8-K: CURRENT REPORT","sentiment":"neutral"},{"date":"2026-01-29","type":"regulatory","source":"SEC EDGAR","summary":"8-K filed with SEC: CURRENT REPORT","headline":"SEC 8-K: CURRENT REPORT","sentiment":"neutral"},{"date":"2025-12-23","type":"regulatory","source":"SEC EDGAR","summary":"8-K filed with SEC: CURRENT REPORT","headline":"SEC 8-K: CURRENT REPORT","sentiment":"neutral"},{"date":"2025-12-08","type":"regulatory","source":"SEC EDGAR","summary":"8-K filed with SEC: CURRENT REPORT","headline":"SEC 8-K: CURRENT REPORT","sentiment":"neutral"},{"date":"2025-11-14","type":"earnings","source":"SEC EDGAR","summary":"10-Q filed with SEC: FORM 10-Q","headline":"Quarterly Report (10-Q) Filed","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMijAFBVV95cUxOM3laYkZidXNmTDdnclNZSWM0YXZhdVNvdEt2Z3ZuUkNrWUYxaG81NGdIQ3pvdk5jU2N5S0M1VXZTelhUQl96WFdfNks0alFiMFZvREFEU2U0SlNJR2FJV2oyOTQ5ZV9sYVlzbFJTVzVRZ2RrVUtWOEtvYmxJSGFqWktTeEJaRnRUUTdGTQ?oc=5","date":"2025-08-26","type":"regulatory","source":"Yahoo Finance","summary":"Allarity Therapeutics Granted FDA Fast Track Designation for Stenoparib for the Treatment of Advanced Ovarian Cancer - Yahoo Finance","headline":"Allarity Therapeutics Granted FDA Fast Track Designation for Stenoparib for the Treatment of Advanced Ovarian Cancer","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":3,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":{"source":"sec_edgar+yahoo","revenue":null,"revenuePeriod":null,"revenueHistory":[],"grossProfit":-2265000,"grossProfitHistory":[],"rdSpend":6601000,"rdSpendHistory":[],"sgaSpend":null,"operatingIncome":null,"operatingIncomeHistory":[],"netIncome":-11231000,"netIncomeHistory":[],"eps":null,"epsHistory":[],"cash":14687000,"cashHistory":[],"totalAssets":18258000,"totalLiabilities":null,"totalDebt":null,"equity":null,"operatingCashflow":null,"operatingCashflowHistory":[],"capex":null,"capexHistory":[],"freeCashflow":null,"dividendsPaid":null,"buybacks":null,"employees":null,"segmentRevenue":[],"geographicRevenue":[],"quarterly":{"income":[]},"ciks":null,"lastFiledAt":null},"yahoo":null}